In this regard, we review the molecular mechanisms controlling the expression levels and specific functions of HIF-1α and HIF-2α and their downstream signalling elements during initiation and progression of leukaemias, glioblastoma multiforme, melanoma and epithelial cancers such as prostate, breast and pancreatic cancers. The gene discussed is EPAS1; the disease is glioblastoma.